Clinical trial efficiency aided by AI-driven insights

The world is becoming more and more digital every day, with artificial intelligence (AI) representing one of the most promising technologies arising from this digitalization.

As AI continues to mature, Cerba Research is leveraging its power to generate early insights ideal for protocol optimization, whether these are part of translational research, clinical trials or eventual commercialization.

Beyond its capacity for process automation, AI is key to providing maximum insight into available clinical trial data.

Cerba Research’s access to demographically rich data from across the globe allows the company to effectively compare patient populations, allowing its clients to locate a geographical area that contains the necessary eligible patient population to study an indication of interest.

The use of data-intensive, AI-driven insights can significantly improve clinical trial efficiency, reduce costs, streamline protocol design and enhance the process of targeted patient enrolment.

For example, extending the use of AI has enabled Cerba Research to better evaluate the efficacy of a treatment, determine the optimal biomarkers for a study and generate significant data from a patient population.

These advances frequently help reduce the number of patients required for a particular study, accelerating a program to market and maximizing any return on investment.

AI has vast potential to transform clinical trial data for the better. Working with a widely recognized and established company like Cerba Research is an excellent first step in developing new, data-driven insights.

These insights will not only benefit studies, but it is also anticipated that these will ultimately become mandatory as the clinical trials industry continues to move forward at great speed.

About Cerba Research

For over 35 years, Cerba Research has been setting the industry standard for exemplary clinical trial conduct. Today, across five continents, with a focus on precision medicine, we are changing the paradigm of the central lab’s role in complex clinical research.

From protocol inception through development and to market, our passionate experts deliver the highest quality specialized and personalized laboratory and diagnostic solutions. Partner with us for the most efficient strategy to actualize your biotech and pharmaceutical products sooner and improve the lives of patients worldwide.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Apr 11, 2023 at 8:05 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cerba Research. (2023, April 11). Clinical trial efficiency aided by AI-driven insights. News-Medical. Retrieved on February 27, 2024 from https://www.news-medical.net/whitepaper/20230316/Greater-clinical-trial-efficiency-through-AI-driven-insights.aspx.

  • MLA

    Cerba Research. "Clinical trial efficiency aided by AI-driven insights". News-Medical. 27 February 2024. <https://www.news-medical.net/whitepaper/20230316/Greater-clinical-trial-efficiency-through-AI-driven-insights.aspx>.

  • Chicago

    Cerba Research. "Clinical trial efficiency aided by AI-driven insights". News-Medical. https://www.news-medical.net/whitepaper/20230316/Greater-clinical-trial-efficiency-through-AI-driven-insights.aspx. (accessed February 27, 2024).

  • Harvard

    Cerba Research. 2023. Clinical trial efficiency aided by AI-driven insights. News-Medical, viewed 27 February 2024, https://www.news-medical.net/whitepaper/20230316/Greater-clinical-trial-efficiency-through-AI-driven-insights.aspx.

Other White Papers by this Supplier